Total results = 14
<div class="gs_r" style="z-index:400"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB0" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW0"><a href="http://dspace.isivast.org.vn/dspace/bitstream/123456789/1856/1/238%E2%80%93263%20Adenosine%20Receptor%20Antagonists%20.pdf" class=yC0><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from isivast.org.vn</span><span class="gs_ggsS">isivast.org.vn <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctu"><span class="gs_ct1">[CITATION]</span><span class="gs_ct2">[C]</span></span> Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility</h3><div class="gs_a">PG Baraldi, MA Tabrizi, S Gessi, PA Borea - ChemInform, 2008 - Wiley Online Library</div><div class="gs_fl"><a href="/scholar?cites=3162647466295729658&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 98</a> <a href="/scholar?q=related:-p1YOh374ysJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=3162647466295729658&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 9 versions</a> <a onclick="return gs_ocit(event,'-p1YOh374ysJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:399"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB1" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW1"><a href="http://ukpmc.ac.uk/articles/PMC3061413" class=yC2><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from ukpmc.ac.uk</span><span class="gs_ggsS">ukpmc.ac.uk <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://pharmrev.aspetjournals.org/content/63/1/1.short" class=yC1>International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptorsâan update</a></h3><div class="gs_a">BB Fredholm, AP IJzerman, <a href="/citations?user=CpSGQFkAAAAJ&amp;hl=en&amp;oi=sra">KA Jacobson</a>&hellip; - Pharmacological  &hellip;, 2011 - ASPET</div><div class="gs_rs">Abstract In the 10 years since our previous International Union of Basic and Clinical <br>Pharmacology report on the nomenclature and classification of adenosine receptors, no <br>developments have led to major changes in the recommendations. However, there have <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=424294382437276843&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 120</a> <a href="/scholar?q=related:qxxeKX5l4wUJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=424294382437276843&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 4 versions</a> <a onclick="return gs_ocit(event,'qxxeKX5l4wUJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:398"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB2" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW2"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437328/" class=yC4><span class="gs_ggsL"><span class=gs_ctg2>[HTML]</span> from nih.gov</span><span class="gs_ggsS">nih.gov <span class=gs_ctg2>[HTML]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0005273610004529" class=yC3>Recent developments in adenosine receptor ligands and their potential as novel drugs</a></h3><div class="gs_a">CE MÃ¼ller, <a href="/citations?user=CpSGQFkAAAAJ&amp;hl=en&amp;oi=sra">KA Jacobson</a> - Biochimica et Biophysica Acta (BBA)- &hellip;, 2011 - Elsevier</div><div class="gs_rs">Medicinal chemical approaches have been applied to all four of the adenosine receptor <br>(AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each. <br>The most recent class of selective AR ligands to be reported is the class of A2BAR <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=13029742680644895700&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 50</a> <a href="/scholar?q=related:1MOV-u7x0rQJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=13029742680644895700&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'1MOV-u7x0rQJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:397"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB3" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW3"><a href="http://www.libreriauniverso.it/pdf/9783540896142.pdf" class=yC6><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from libreriauniverso.it</span><span class="gs_ggsS">libreriauniverso.it <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/k8p8gr44h7172p23.pdf" class=yC5>A 1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers</a></h3><div class="gs_a">WF Kiesman, E Elzein, J Zablocki - Adenosine Receptors in Health and  &hellip;, 2009 - Springer</div><div class="gs_rs">Intense efforts of many pharmaceutical companies and academicians in the A 1 adenosine <br>receptor (AR) field have led to the discovery of clinical candidates that are antagonists, <br>agonists, and allosteric enhancers. The A 1 AR antagonists currently in clinical <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=13705749144795804988&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 24</a> <a href="/scholar?q=related:PPUqJDuaNL4J:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=13705749144795804988&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 7 versions</a> <a onclick="return gs_ocit(event,'PPUqJDuaNL4J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:396"><div class="gs_ri"><h3 class="gs_rt"><a href="http://pubs.acs.org/doi/abs/10.1021/jm0605381" class=yC7>Potent and orally bioavailable 8-bicyclo [2.2. 2] octylxanthines as adenosine A1 receptor antagonists</a></h3><div class="gs_a">WF Kiesman, J Zhao, PR Conlon&hellip; - Journal of medicinal  &hellip;, 2006 - ACS Publications</div><div class="gs_rs">In the search for a selective adenosine A1 receptor antagonist with greater aqueous <br>solubility than the compounds currently in clinical trials as diuretics, a series of 1, 4-<br>substituted 8-cyclohexyl and 8-bicyclo [2.2. 2] octylxanthines were investigated. The <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=8543876104650285187&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 21</a> <a href="/scholar?q=related:g-CgvgzykXYJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=8543876104650285187&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'g-CgvgzykXYJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:395"><div class="gs_ggs gs_fl"><button type="button" id="gs_ggsB5" class="gs_btnFI gs_in_ib gs_btn_half"><span class="gs_wr"><span class="gs_bg"></span><span class="gs_lbl"></span><span class="gs_ico"></span></span></button><div class="gs_md_wp" id="gs_ggsW5"><a href="http://nashaucheba.ru/docs/9/8900/conv_1/file1.pdf#page=164" class=yC9><span class="gs_ggsL"><span class=gs_ctg2>[PDF]</span> from nashaucheba.ru</span><span class="gs_ggsS">nashaucheba.ru <span class=gs_ctg2>[PDF]</span></span></a></div></div><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.springerlink.com/index/HW7166V3WL807504.pdf" class=yC8>Xanthines as adenosine receptor antagonists</a></h3><div class="gs_a">CE MÃ¼ller, <a href="/citations?user=CpSGQFkAAAAJ&amp;hl=en&amp;oi=sra">KA Jacobson</a> - Methylxanthines, 2011 - Springer</div><div class="gs_rs">The natural plant alkaloids caffeine and theophylline were the first adenosine receptor (AR) <br>antagonists described in the literature. They exhibit micromolar affinities and are non-<br>selective. A large number of derivatives and analogues were subsequently synthesized <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=6732449373760795855&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 14</a> <a href="/scholar?q=related:zzRQDwl3bl0J:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=6732449373760795855&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'zzRQDwl3bl0J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:394"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.ingentaconnect.com/content/govi/pharmaz/2009/00000064/00000012/art00001" class=yCA>Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure-activity relationships</a></h3><div class="gs_a">F Azam, IA Ibn-Rajab, AA Alruiad - Die Pharmazie-An  &hellip;, 2009 - ingentaconnect.com</div><div class="gs_rs">Abstract: The adenosine A 2A receptor (AA2AR) has emerged as an attractive target for the <br>treatment of Parkinson&#39;s disease. Evidence suggests that antagonists of the AA 2A R may be <br>neuroprotective and may help to alleviate the symptoms of Parkinson&#39;s disease. During <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=5819782922132000584&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 13</a> <a href="/scholar?q=related:SA-Qr7sFxFAJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=5819782922132000584&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'SA-Qr7sFxFAJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:393"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.ingentaconnect.com/content/ben/ctmc/2010/00000010/00000009/art00003" class=yCB>A1 receptors ligands: past, present and future trends</a></h3><div class="gs_a">S Schenone, C Brullo, F Musumeci&hellip; - Current topics in  &hellip;, 2010 - ingentaconnect.com</div><div class="gs_rs">Abstract: Adenosine is a neuromodulator that interacting with four receptors, A1, A2A, A2B <br>and A3, is involved in the regulation of several biological functions in different organs and <br>tissues, including the central nervous system, the cardiovascular system and the airways; <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=10718938884522465483&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 10</a> <a href="/scholar?q=related:y1gVxR9SwZQJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=10718938884522465483&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 2 versions</a> <a onclick="return gs_ocit(event,'y1gVxR9SwZQJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:392"><div class="gs_ri"><h3 class="gs_rt"><span class="gs_ctc"><span class="gs_ct1">[BOOK]</span><span class="gs_ct2">[B]</span></span> <a href="http://books.google.com/books?hl=en&amp;lr=&amp;id=nVb40Xmje4kC&amp;oi=fnd&amp;pg=PP2&amp;ots=TMwjE67Qh3&amp;sig=h18jzmb5uU3UZ22Rpv0H5Q5Ikvs" class=yCC>Progress in Heterocyclic Chemistry, Volume 8: A critical review of the 1995 literature preceded by two chapters on current heterocyclic topics</a></h3><div class="gs_a">H Suschitzky - 1996 - books.google.com</div><div class="gs_rs">Progress in Heterocyclic Chemistry (PHC) is an annual review series commissioned by the <br>International Society of Heterocyclic Chemistry (ISHC). The volumes in the series contain <br>both highlights of the previous year&#39;s literature on heterocyclic chemistry and articles on <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=10574512454767670533&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 3</a> <a href="/scholar?q=related:BfVeKw03wJIJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=10574512454767670533&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 2 versions</a> <a onclick="return gs_ocit(event,'BfVeKw03wJIJ')" href="#" class="gs_nph">Cite</a> <div class="gs_rm_dd gs_nph"><a href="#" class="gs_rm_l" onclick="return gs_md_opn('gs_rm_md8', event)">More<span class="gs_ico"></span></a><div id="gs_rm_md8" class="gs_md_wn" style="display:none">  <a href="/scholar?q=info:BfVeKw03wJIJ:scholar.google.com/&amp;output=instlink&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5&amp;scillfp=14162051458803826718&amp;oi=llo" class="gs_md_li">Library Search</a></div>  </div>  </div></div></div>
<div class="gs_r" style="z-index:391"><div class="gs_ri"><h3 class="gs_rt"><a href="http://informahealthcare.com/doi/abs/10.1517/17460441.2.9.1161" class=yCD>Novel 8-heterocyclyl xanthine derivatives in drug development-an update</a></h3><div class="gs_a">PG Baraldi, F Fruttarolo, MA Tabrizi, R Romagnoli&hellip; - 2007 - informahealthcare.com</div><div class="gs_rs">Naturally occurring methyl xanthines, especially caffeine and theophylline, have been <br>widely investigated for their pharmacological properties as cognition enhancers, <br>bronchodilator agents and mild diuretics. The xanthine core (3, 7-dihydro-1H-purine-2, 6-<b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=217003475438524547&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 3</a> <a href="/scholar?q=related:g9iJ3ILzAgMJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=217003475438524547&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 2 versions</a> <a onclick="return gs_ocit(event,'g9iJ3ILzAgMJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:390"><div class="gs_ri"><h3 class="gs_rt"><a href="http://jcp.sagepub.com/content/51/7/1004.short" class=yCE>Clinical Pharmacokinetics of Tonapofylline Evaluation of Dose Proportionality, Oral Bioavailability, and Gender and Food Effects in Healthy Human Subjects</a></h3><div class="gs_a">Z Li, C TenHoor, T Marbury, S Swan&hellip; - The Journal of  &hellip;, 2011 - jcp.sagepub.com</div><div class="gs_rs">Abstract Tonapofylline is an antagonist of adenosine A1 receptor being developed for heart <br>failure. In the present studies, pharmacokinetic characteristics, including dose <br>proportionality, bioavailability, and effects of gender and food, were evaluated in healthy <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=3711663581474747962&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 2</a> <a href="/scholar?q=related:OnaOs1x6gjMJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=3711663581474747962&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 5 versions</a> <a onclick="return gs_ocit(event,'OnaOs1x6gjMJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:389"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0223523411004016" class=yCF>Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido-and diazepinopurinediones</a></h3><div class="gs_a">A DrabczyÅska, <a href="/citations?user=LsXmxEUAAAAJ&amp;hl=en&amp;oi=sra">O Yuzlenko</a>, M KÃ¶se&hellip; - European journal of  &hellip;, 2011 - Elsevier</div><div class="gs_rs">Syntheses and physicochemical properties of N-cycloalkyl-substituted imidazo-, pyrimido-<br>and 1, 3-diazepino [2, 1-f] purinediones are described. These derivatives were synthesized <br>by cyclization of 7-halogenoalkyl-8-bromo-1, 3-dimethylxanthine derivatives with <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=6197744607280148437&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 2</a> <a href="/scholar?q=related:1a-GHeLPAlYJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=6197744607280148437&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 3 versions</a> <a onclick="return gs_ocit(event,'1a-GHeLPAlYJ')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:388"><div class="gs_ri"><h3 class="gs_rt"><a href="http://www.sciencedirect.com/science/article/pii/S0959638008800177" class=yC10>.3 Triazines, tetrazines and fused ring polyaza systems</a></h3><div class="gs_a">P Goya, C Gomez de la Oliva - Progress in Heterocyclic Chemistry, 2008 - Elsevier</div><div class="gs_rs">414 Chapter 6.3 Triazines, tetrazines and fused ring polyaza systems Pilar Goya and <br>Cristina G6mez de la Oliva Instituto de Quimica M# dica (CSIC), Juan de la Cierva, 3, 28006 <br>Madrid, Spain e-mail: iqmg310@ iqm. csic. es 6.3. 1 TRIAZINES 6.3. 1.1 1, 2, 3-Triazines <b> ...</b></div><div class="gs_fl"><a href="/scholar?cites=9154275447687857695&amp;as_sdt=2005&amp;sciodt=0,5&amp;hl=en&amp;num=14">Cited by 1</a> <a href="/scholar?q=related:H8aDqwSFCn8J:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a href="/scholar?cluster=9154275447687857695&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">All 3 versions</a> <a onclick="return gs_ocit(event,'H8aDqwSFCn8J')" href="#" class="gs_nph">Cite</a></div></div></div>
<div class="gs_r" style="z-index:387"><div class="gs_ri"><h3 class="gs_rt"><a href="http://books.google.com/books?hl=en&amp;lr=&amp;id=yyDvGWSNNqgC&amp;oi=fnd&amp;pg=PA151&amp;ots=WXTmOdc5TQ&amp;sig=wYqfZwUTieIvM1dbQKTeHE87xgw" class=yC11>Xanthines as Adenosine Receptor Antagonists</a></h3><div class="gs_a"><a href="/citations?user=CpSGQFkAAAAJ&amp;hl=en&amp;oi=sra">KA Jacobson</a> - Methylxanthines, 2010 - books.google.com</div><div class="gs_rs">Abstract The natural plant alkaloids caffeine and theophylline were the ï¬rst adenosine <br>receptor (AR) antagonists described in the literature. They exhibit micromolar afï¬nities and <br>are non-selective. A large number of derivatives and analogues were subsequently <b> ...</b></div><div class="gs_fl"><a href="/scholar?q=related:VFjdsKy0DBQJ:scholar.google.com/&amp;hl=en&amp;num=14&amp;as_sdt=0,5&amp;sciodt=0,5">Related articles</a> <a onclick="return gs_ocit(event,'VFjdsKy0DBQJ')" href="#" class="gs_nph">Cite</a></div></div></div>
